Logo for Corline Biomedical

Corline Biomedical Investor Relations Material

Latest events

Logo for Corline Biomedical

Q1 2024

30 Apr, 2024
Logo for Corline Biomedical

Q4 2023

14 Feb, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Corline Biomedical

Access all reports
Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and regenerative medicine applications. Its products are based on Corline Heparin Conjugate (CHC) technology, a heparin conjugate that is used as stand-alone pharmaceutical compound.